The first clinical trial to compare two commonly used drugs head-to-head for venous thrombosis treatment has found a clear winner: while both drugs work well to prevent recurrent blood clots, apixaban ...

March 13 (Reuters) - A trial directly comparing Eliquis and Xarelto - two commonly used blood-thinning drugs from the same ...

Every year, nearly 900,000 Americans are affected by venous thromboembolism (VTE), a condition in which blood clots form in ...

A trial directly comparing two commonly used blood-thinning drugs found that one carries a lower risk of dangerous bleeding ‌in patients with clots in veins deep in the body, researchers reported in ...

GRAND RAPIDS, Michigan — March is National Blood Clot Awareness Month, and this past year, Corewell Health's Butterworth Hospital has been named a Center of Excellence by the National Blood Clot ...

According to CDC estimates, as many as 900,000 people are affected by blood clots each year in the United States. Although serious, this medical condition is both preventable and treatable, if ...

It's an extremely common and effective medication used to prevent and break up blood clots and as part of a treatment protocol for atrial fibrillation (AFib). But does Eliquis have side effects? We as ...

The Johns Hopkins Armstrong Institute for Patient Safety and Quality leads national VTE prevention efforts through its Venous Thromboembolism (VTE) Collaborative, which aims to advance evidence-based ...

The Johns Hopkins Armstrong Institute for Patient Safety and Quality offers a video and handout aimed at helping patients better engage in preventing blood clots. The two-page handout, that covers ...

A new statement from leading heart and blood vessel experts in Europe is providing clinical guidance for treatments to prevent blood clots in patients with a serious condition called chronic ...